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Antituberculous treatment combined with
corticoids has been much studied in the field of
internal medicine. Recently many reported that
this combined therapy was effective against
tuberculosis, particularly for meningitis, miliary
tuberculosis, exudative pleurisy and pericarditis,
and sometimes for active pulmonary tuberculosis.
Longhin (1) and Lapière (2) reported that this
combined therapy was effective against cutaneous
tuberculosis. Kalkoff (1952) (3) stated that he
had treated one case of lupus vulgaris with ACTH
for a short period with considerable benefit.
From a practical point of view in the treatment
of tuberculosis, corticoids should be used ad-
ministered simultaneously with antituberculosis
remedies. This procedure, however, would make
it impossible to determine the effect of the indi-
vidual remedies,
Therefore, an attempt was made to treat the
patients with skin tuberculosis with eortieoids
only. For this purpose corticoid therapy was ad-
ministered to patients with lupus vulgaris, a typi-
cal cutaneous tuberculosis, and to patients with
lupus miliaris disseminatus faeiei, one of the
tuberculids.
MATERIALS AND METHODS
All of the patients, 7 cases of lupus vulgaris and
9 of lupus miliaris disseminatus I aciei, were ob-
served in the skin clinic of Kyoto University. All
patients were Japanese. The cortieoids used were
prednisolone, dexamethasone, triamcinolone or
methylprednisolone. An average daily dose of 15
mg. of prednisolone, 1.5 mg. of dexamethasone, 12
mg. of triameinolone or 12 mg. of methyipredniso-
lone was given until an apparent clinical cure was
obtained. The duration of hormone therapy varied
in each ease.
In lupus vulgaris there was no flare-up of the
condition after reduction of the dose or with-
drawal of eortieoids. Therefore, in lupus vulgaris
corticoids were discontinued within a month after
clinical cure. But in lupus miliaris disseminatus
faciei, there was often a flare-up of the condition
after their reduction of the dose or after with-
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drawal. The dose of corticoids was therefore in-
creased when a flare-up occurred.
In each case of lupus vulgaris two specimens of
tissue were obtained by punch biopsy both on
admission and during the course of cortieoid treat-
ment. One of these was cultured and the other was
implanted into the abdominal cavity of a guinea-
pig. In 4 of 7 eases tuberele bacilli were demon-
strated; these were sensitive to INH.
Chest x-rays taken both on admission and at
monthly intervals during eortieoids administra-
tion. There was no evidence of active pulmonary
tuberculosis.
RESULTS
1. Lupus vulgaris
Seven patients, 2 males and 5 females, with
lupus vulgaris were treated with oral adminis-
tration of eortieoids. The age ranged from 32 to
55 years. Tuberele bacilli were proved in 4 of 7
cases. All patients responded well to corticoids.
Skin lesions began to improve within a week, be-
coming less red and less elevated.
One month later, bacteriological examination
was negative for tuberele bacilli in all the cases.
In 2 months, histologic examination revealed
that the features of typical tuberculous nodules
in skin lesions marked by epithelioid and giant
cells were replaced by those of banal inflammation
associated with perivascular infiltation of lympho-
cytes and fibroblasts. There were no active skin
lesions in any ease after 4 to S months' corticoids
administration. When clinical symptoms sub-
sided corticoid therapy was discontinued. The
histories of 3 representative cases are as follows.
Case 1. A 34-year-old female with a past history
of Pott's disease at the age of 24, and lupus vul-
garis at 31 which worsened gradually leaving
characteristic plaques of small tubereles on the
face. She had never been put on antitubcrculosis
remedies. Both chest x-rays for tuberculosis and
culture and animal experiment for tuberele bacilli
were negative on admission. Following adminis-
tration of dexamethasone in daily doses of
1.5 mg., the skin lesions began to improve within
a week, becoming less red and less elevated.
A bacteriologic examination for tuberclc bacilli
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carried out one month later was nlso negative.
The papular lesions were flattened in 77 days
with histologic features of banal inflammation re-
placing typical tuberculous nodules found on ad-
mission (Fig. 1 (a)—(d)).
Dexamethasone was discontinued and methyl-
prednisolone administered in daily doses of 12
mg. in about 9 weeks \Vhen secondary corticoid
effects developed (acne, marked moon face and
increase of appetite and weight). Thereafter the
appetite and weight returned almost to normal,
though the acne and moon face persisted.
The cortieoid was given in gradually decreas-
ing doses after clinical cure was established in 133
days, and was discontinued in a month there-
after.
Case 2. A 55-year-old female with long-lasting,
progressive, centrifugal plaque of small tubereles
on the right side of the neck since the age of 24.
Chest x-rays for tuberculosis and culture and
animal inoculation for tuberele bacilli were
negative. Prednisolone 15 mg. daily was given.
Some improvement of the lesion was observed
within one week. After a month bacteriological
examination of the lesion for tuberele bacilli was
again negative. Two months' treatment resulted
in the flattening of tubereles in the lesion and in a
change of histologic features from typical tuber-
eulous nodules to that of a banal inflammation.
The tubercles disappeared in 4 months leaving
flattened scars (Fig. 2 (a)—(b)). There was no
side-effect except for a slight degree of moon
face. Prednisolone was gradually reduced and
finally discontinued one month after the clinical
cure.
Case 3. A 32-year-old male with a history of
]upus vulgaris since 16 years of age. The lesions
spread from the lateral angle of the left orbit to
both sides of the cheeks and cars, the nose, the
upper lip and the left side of the neck, leaving
irregular scars with nodules and ulcers around
them in the corresponding regions. A skiagram
revealed no underlying bone changes. The pa-
tient had never been given antituberculosis
remedies. Both the culture from the lesions and
animal inoculation were positive for mycobae-
terium tuberculosis. Chest x-rays were negative
on admission. Predniso]one was given 15 mg.
daily and was followed by some improvement of
the lesions within a week.
After 34 days, both culture and animal inocula-
tion were negative for Mycobacterium tuberculosis.
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After 9 months' treatment, the histology were
marked by perfect epithelization of ulcers and
banal inflammation replacing typical tuberculous
nodules.
The dosage was gradually reduced after the
clinical cure was obtained in 4 months and all
medications were discontinued 5 months after
the start treatment. A slight relapse of the ulcers
appeared 10 months after discontinuance of the
treatment. Prednisolone was again prescribed
(15 mg. daily), and the clinical symptoms sub-
sided in a month.
In 4 cases of the 7, INH was administered to
ensure the permanent cure after the dramatic
improvement with the single course of corticoid.
The INH medication was continued for about 2
years with successful control of the disease. How-
ever, 2 of the 3 cases treated without supplemen-
tary INH therapy, slight recurrences of the
lesions occurred in 2 patients after about one
year of the discontinuance of corticoids and
necessitated resuming corticoid therapy. One
eortieoid-treated ease without supplementary
INH has remained cured for 2 years after the dis-
continuance of corticoids.
2. Lupus miliaris dissensinatus faciei
Nine patients, 5 males and 4 females, with
lupus miliaris disseminatus faeiei were treated
with eorticoid. The age ranged from 21 to 46
years. All patients had non-ulcerative tubereles
with the exception of 2 patients who did have
ulceration.
All patients received desamethasone in daily
doses of 1.5 mg. Some of the maeulopapular
lesions disappeared within 2 weeks. Most of
papular lesions were flattened after 1 to 2 months'
treatment. (Fig. 3 (a)—(b)). After 4 to 6 months'
treatment all the lesions were flattened with
eicatrieial healing. Dexamethasone was then
gradually reduced. As relapses occurred in all
the eases, the original dosages were resumed.
Thereafter the maintenance dose necessary for
clinical cure for each patient was determined. In
5 of the 9 patients, the maintenance doses were
given in combination with INH. The combined
therapy was continued for 1 to 2 years and com-
plete cure was obtained in these 5 eases within 3
years.
The remaining 4 eases (including the above-
mentioned exceptional 2 eases with necrotic
ulcers) were treated only with eortieoids and were
cured within 3 years. All of the 9 patients have
had no recurrences for over 6 months.
In each ease histologic examination was done
on admission, after a month's treatment and
when apparent clinical cure was obtained after 4
to 6 months' treatment. In the lesions treated for
a month, fewer epithelioid cells, fewer giant cells
and many more fibroblasts were found (Fig.
3 (c)—(d)). In the lesions showing apparent clini-
cal cure, the histologic features were found to
have changed from typical tubereles to banal in-
flammation ivith extensive fibrosis.
COMMENTS
Corticoid therapy for lupus vulgaris and lupus
miliaris disseminatus faeiei was studied. In this
experiment, antitubereulosis remedies ordinarily
given in combination with cortieoids, were not
administered during certain periods in order to
observe the effect induced only by the latter.
In each case, chest x-rays were negative for
tuberculosis at the first consultation. Extreme
t
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care was taken to observe possible side-effects of
the drug; and chest x-rays repeatedly taken
during the course of corticoid administration
were all negative for pulmonary tuberculosis.
In all the cases of lupus vulgaris the clinical
symptoms were successfully controlled by the
administration of corticoids. Both culture and
animal inoculation of the lesions were negative
for tubercle bacilli after a month of treatment.
After the clinical symptoms subsided, corticoid
therapy was discontinued. Thereafter 3 of 7
cases were observed and found not to require
further medication. Slight recurrences of the
lesions occurred in 2 of these 3 eases about one
year after discontinuance of the treatment. The
other 4 cases out of 7 were treated with INH
after discontinuance of corticoids. No relapses
occurred for 2 years in all the cases treated with
INH (and one ease with no antitubereulosis reme-
dies) after discontinuance of eorticoids.As relapses
occurred in about one year only in those eases to
which no antitubereulosis remedies were given
following the successful management by eorti-
coids, it seems reasonable to assume that the
bacilli remained, more or less, in the lesions
even when clinical cure was established.
In all eases of lupus miliaris disseminatus faeiei
treated with eortieoids, clinical symptoms sub-
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sided and histologic features of tubereulous
nodules were replaced by those of banal inflam-
mation with fibrosis. Then, reduced doses of
cortieoids were given in 5 of 9 eases in combina-
tion with antitubereulosis remedies and in the
remaining 4 eases with no antitubereulosis
remedies. Although relapses of varying degree
occurred in all the eases, all of the patients were
finally cured.
There were no apparent differences between
the clinical course of the 4 eases treated without
additional antitubereulosis remedies and that of
the 5 eases having the combined therapy.
Cortieoids are especially useful for cosmetic
purpose both in lupus vulgaris and in lupus
miliaris disseminatus faciei, since the former
most frequently and the latter with no exception
occur on the face, leaving sears.
However, for practical considerations, it is
recommended that the antitubereulosis remedies
be combined with the eortieoids.
SUMMARY
A clinical trial of eortieoid therapy in lupus
vulgaris and lupus miliaris disseminatus faeiei is
reported.
The results of therapy were excellent without
supplementary use of antitubereulosis remedies.
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